Understanding Your Laboratory Test: A Patient Guide
This test measures the level of acetylcarnitine in your blood to help evaluate your body's energy metabolism and carnitine status.
{"Acetylcarnitine is a form of carnitine that helps produce cellular energy","The test is commonly used to screen for inherited metabolic disorders","It may also help assess liver function and certain neurological conditions","A blood sample is drawn from a vein in your arm","Results help doctors diagnose and monitor specific metabolic conditions"}
Key facts at a glance
- LOINC
- 18436-6
- Short code
- AC C2
- Synonyms
- Acetylcarn SerPl-mCnc
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or plain red top tube
- Units
- N/A
- Ref low
- 2
- Ref high
- 8
- Critical range
- 1 N/A – 15 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- Tandem Mass Spectrometry (LC-MS/MS)
- CPT
- 82017
- SNOMED
- 314255006
- Specimen volume
- 1.0 mL serum minimum
- Stability
- Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C): 30 days
- Hemolysis max
- 50
- Lipemia max
- 300
- Icterus max
- 20
- TAT
- 24–72 hours
- Order
- routine
This test is a laboratory procedure that gives your healthcare provider important information about your health. It measures specific substances in your body, and the results can help detect, diagnose, or monitor medical conditions so you receive the most appropriate care.
The acetylcarnitine (C2) test measures the amount of acetylcarnitine in your serum or plasma. Acetylcarnitine is a naturally occurring molecule derived from the amino acid lysine and plays a crucial role in energy production. It helps transport fatty acids into the mitochondria, where they are burned for energy. This test is part of a broader group of tests called acylcarnitine profile analysis, which evaluates various forms of carnitine in the blood.
Your doctor may recommend this test if you have symptoms that need an explanation, if you have a chronic condition that requires regular monitoring, or as part of a routine checkup. The results help guide treatment decisions and can identify potential health problems early, before they become more serious.
Your doctor may order this test for several reasons: (1) Newborn screening - to detect inherited metabolic disorders such as carnitine palmitoyltransferase (CPT) deficiencies, (2) Evaluating symptoms like muscle weakness, fatigue, or metabolic crises, (3) Assessing liver function or heart muscle problems, (4) Monitoring patients with known metabolic disorders, or (5) Investigating unexplained hypoglycemia or cardiomyopathy. The test is particularly important for infants and children with suspected metabolic conditions.
The test is typically performed by a trained healthcare professional who will collect a small sample, such as blood, urine, or tissue, depending on what your provider has ordered. The collection usually takes only a few minutes, and the sample is then sent to a laboratory where it is carefully analyzed. Your results will be shared with you once they are available.
A healthcare professional will draw a small blood sample from a vein in your arm using a needle. The blood will be collected in a tube and sent to a laboratory for analysis. The procedure only takes a few minutes and is generally well-tolerated. For newborns, the sample may be collected via a heel stick. You typically do not need to fast before this test, but follow your doctor's specific instructions.
This test is generally very safe, and serious complications are rare. You may experience mild, temporary discomfort where the sample was collected, such as slight pain, bruising, or bleeding. If you notice persistent pain, swelling, or signs of infection, contact your healthcare provider. Always tell your care team about any allergies or medications you take before the test.
The risks associated with this blood test are minimal and include slight pain or bruising at the needle site, lightheadedness, and in rare cases, infection. These risks are generally temporary and resolve quickly. The benefits of obtaining important diagnostic information far outweigh these minor, temporary discomforts.
Reference range
Reference range: 2.0-8.0 µmol/L (may vary by laboratory method)N/A
No special preparation required. Avoid vitamin supplements containing carnitine 24 hours prior to collection if possible.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Elevated acetylcarnitine levels may indicate: inherited metabolic disorders (such as CPT I or CPT II deficiency), liver disease, kidney disease, or certain medications that affect carnitine metabolism. Decreased levels may be seen in malnutrition, carnitine deficiency, or certain genetic conditions. The test is especially valuable for diagnosing fatty acid oxidation disorders, which are serious conditions where the body cannot properly break down fats for energy. Early detection through newborn screening has significantly improved outcomes for affected children by allowing early intervention and treatment.
Frequently asked questions
Do I need to fast before the test?
How long does it take to get results?
What happens if my results are abnormal?
Is this test only for children?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 10, 2026. · Read our editorial policy